Molecular changes in oral cancer may reflect aetiology and ethnic origin

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 3, 1996, Pages 150-153

  Paterson, I C ^a   Eveson, J W ^a   Prime, S S ^a  

^a Division of Oral Medicine   (United Kingdom)

Author keywords

Oral cancer; p53 mutation; ras mutation; Tobacco

Indexed keywords

PROTEIN P53;

ETHNIC DIFFERENCE; GENE MUTATION; HUMAN; MOUTH CANCER; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0029937141     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00065-8     Document Type: Review

References (60)

1. Wynder EL, Bross IJ, Feldman RM. A study of the etiological factors in cancer of the mouth. Cancer 1957, 10, 1300-1323.
2. Graham S. Dentition, diet, tobacco and alcohol in the epidemiology of oral cancer. J Natl Cancer Inst 1977, 59, 1611-1618.
3. Thomas S, Kearsley J. Betel quid and oral cancer: a review. Oral Oncol, EurJ Cancer 1993, 29B, 251-255.
4. World Health Organisation Meeting-Control of oral cancer in developing countries. Bull WHO 1984, 62, 817-830.
5. Stitch HF, Rosin MP, Harnby AP, Sankaranarayanan R, Nair MK. Remission of oral leukoplakias and micronuclei in tobacco/ betel quid chewers treated with beta-carotene and with betacarotene plus vitamin A. Int J Cancer 1988, 421, 195-199.
6. La vecchia C, Franceschi S, Levi F, Lucchini F, Negri E. Diet and human oral carcinoma in Europe. Oral Oncol, Eur J Cancer 1993, 29B, 17-22.
7. Cancer Research Campaign Factsheet 14. 1993. Oral Cancer 14.1-14.5.
8. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Palhol 1990, 69, 325-330.
9. Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T, Scully C, Tedesco B. Epidemiology of mouth cancer in 1989: a review. J R Soc Med 1990, 83, 724-730.
10. Macfarlane GL, Boyle P, Scully C. Oral cancer in Scotland: changing incidence and mortality. Er Med J 1992, 305, 1121-1123.
11. MacDonald DG. Premalignant lesions of oral epithelium. In Dolby AE, ed. Oral Mucosa in Health and Disease. Oxford, Blackwell Scientific Publications, 1975, 335-369.
12. Moore C, Catlin D. Anatomic origins and locations of oral cancer. Am J Surg 1967, 114, 510-513.
13. Smith CJ. Epidemiology and aetiology. In Langdon JD, Henk JM, eds. Malignant Tumours of the Mouth, Jaws and Salivary Glands. London, Edward Arnold, 1995, 1-13.
14. Brachman DG, Graves D, Yokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992, 52, 4832-4836.
15. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993, 67, 1274-1284.
16. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993, 53, 4477-4480.
17. Caamano J, Zhang SY, Rosvold EA, Bauer B, Klein-Szanto AJP. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. AmJPathol 1993, 142, 1131-1139.
18. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993, 53, 1675-1683.
19. Sakai E, Rikimaru K, Ueda M, et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Im J Cancer 1992, 52, 867-872.
20. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992, 52, 5997-6000.
21. Soo Kim M, Li S-L, Bertolami CN, Cherrick HM, Park N-H. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res 1993, 13, 1405-1414.
22. Thomas S, Brennan J, Martel G, et al. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 1994, 54, 3588-3593.
23. Xu L, Chen Y-T, Huvos AG, et al. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diag Mol Pathol 1994, 3(2), 83-92.
24. Yeudall WA, Paterson 1C, Patel V, Prime SS. Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53 protein. Oral Oncol, EurJ Cancer 1995, 31B, 136-143.
25. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, Schafer R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node métastases. Int J Cancer 1994, 56, 807-811.
26. Chang Y-S, Lin Y-J, Tsai C-N, et al. Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Letts 1992, 67, 167-174.
27. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogcne 1992, 7, 927-933.
28. Ranasinghe A, Macgeoch C, Dyer S, Spurr N, Johnson NW. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5-9. Anticancer Res 1993, 13, 2065-2068.
29. Anderson JA, Irish JC, McLachlin CM, Ngan BY. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 1994, 120, 755-760.
30. Clark LJ, Edington K, Swan IRC, et al. The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Br J Cancer 1993, 68, 617-620.
31. Warnakulasuriya KAAS, Chang SE, Johnson NW. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinoma, but are infrequent in British cases. J Oral Pathol Med 1992, 21, 225-229.
32. Yeudall WA, Torrance LK, Elsegood KA, Speight P, Scully C, Prime SS. ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissue from oral mucosal lesions. Oral Oncol, EurJ Cancer 1993, 29B, 63-67.
33. Chang SE, Bhatia P, Johnson NW, et al. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer 1991,48,409-412.
34. Irish JC, Bernstein A. Oncogenes in head and neck cancer. Laryngoscope 1993, 103, 42-52.
35. Kuo MYP, Jeng JH, Chiang CP, Hahn LJ. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 1994, 23, 70-74.
36. Saranath D, Chang SE, Bhoite LT, et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991, 63,573-578.
37. Somers KD, Cartwright SL, Schechter GL. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 1990, 5, 915-920.
38. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK. Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer 1991, 48, 511-515.
39. Ishitoya J, Toriyama M, Oguchi N, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989, 59, 559-562.
40. Merritt WD, Weissler MC, Turk BF, Gilmer TM. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1990, 116, 1394-1398.
41. Veiling P, Jungehulsing M, Stutzer H, Diehl V, Tesch H. Analysis of proto-oncogenes in squamous cell carcinomas of the head and neck (SCCHN). Int J Oncology 1993 3, 671-677.
42. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi VD, Deo MG. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Oral Oncol, Eurjf Cancer 1992, 28, 139-143.
43. Berenson JR, Yang J, Mickel R. Frequent amplification of the bcl1 locus in head and neck squamous cell carcinomas. Oncogene 1989, 4, 1111-1116.
44. Paterson 1C, Patel V, Sandy JR, Prime SS, Yeudall WA. Effects of TGF-l on growth-regulatory genes in tumour-derived human oral keratinocytes. Er J Cancer 1995, 72, 922-927.
45. Saranath D, Panchal RG, Nair R, et al. Oncogene amplification in squamous cell carcinoma of the oral cavily.jpnj Cancer Res 1989, 80, 430-437.
46. Saranath D, Bhoite LT, Deo MG. Molecular lesions in human oral cancer : the Indian scene. Oral Oncol, Eurjf Cancer 1993,29B, 107-112.
47. Kiaris H, Spandidos DA, Jones AS, Field JK. Loss of heterozygosity and microsatellite instability of the H-ras gene in cancer of the head and neck. Int J Oncol 1994, 5, 579-582.
48. Nées M, Homann N, Discher H, et al. Expression of mutated p 53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993, 53, 4189-4196.
49. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992, 70, 523-526.
50. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54, 4855-4878.
51. Lane DP. p53 and human cancers. Br Med Bull 1994, 50, 582-599.
52. Warnakulasuriya KAAS, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992, 21, 404-408.
53. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol 1992, 166,389-394.
54. Field JK, Spandidos DA, Stell PM. Overexpression of p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet 1992, 339, 502-503.
55. Matthews JB, Scully C, Jovanovic A, Van der Waal I, Yeudall WA, Prime SS. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncol, Eur J Cancer 1993, 29B, 285-289.
56. Yeudall WA, Crawford RY, Ensley JF, Robbins, KG. MTS1,' CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 1994, 15, 2683-2686.
57. Kiaris H, Spandidos DA, Jones AS, Vaughan ED, Field JK. Mutations, expression and genomic instability of the H-ras protooncogene in squamous cell carcinomas of the head and neck. Br J Cancer 1995,72, 123-128.
58. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutât Res 1983, 114, 59-89.
59. Nishikawa A, Prokopczyk B, Rivenson A, Zang E, Hoffman D. A study of betel quid carcinogenesis-VIII. Carcinogenicity of 3(methylnitrosamino) propionaldehyde in F344 rats. Carcinogenesis 1992, 13, 369-372.
60. Paymaster JC. Cancer of the buccal mucosa : a clinical study of 650 cases in Indian patients. Cancer 1956, 9, 431-435.